Surgery Partners (NASDAQ:SGRY – Get Free Report) had its price target increased by analysts at Royal Bank Of Canada from $23.50 to $25.00 in a research note issued on Tuesday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank Of Canada‘s target price would suggest a potential downside of 6.44% from the company’s previous close.
A number of other brokerages also recently issued reports on SGRY. JPMorgan Chase & Co. increased their price target on Surgery Partners from $14.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, September 14th. UBS Group lowered shares of Surgery Partners from a “buy” rating to a “hold” rating and raised their target price for the company from $21.00 to $23.50 in a research report on Wednesday, October 28th. Benchmark restated a “buy” rating on shares of Surgery Partners in a report on Tuesday, August 11th. TD Cowen downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a report on Saturday, October 31st. Finally, Zacks Research downgraded shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 10th. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.27.
Read Our Latest Stock Analysis on Surgery Partners
Surgery Partners Stock Performance
Shares of SGRY traded up $0.27 during trading hours on Tuesday, hitting $26.72. The company had a trading volume of 817,093 shares, compared to its average volume of 2,222,740. The firm has a market cap of $3.50 billion, a price-to-earnings ratio of -38.22 and a beta of 1.85. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. Surgery Partners has a 12 month low of $11.41 and a 12 month high of $27.23. The business has a fifty day moving average of $16.29 and a 200-day moving average of $14.88.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The company had revenue of $815.30 million during the quarter, compared to analysts’ expectations of $820.96 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. The business’s revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.13 earnings per share. Equities analysts anticipate that Surgery Partners will post 0.07 EPS for the current fiscal year.
Insider Transactions at Surgery Partners
In other news, Director Teresa DeLuca bought 10,000 shares of the stock in a transaction on Tuesday, August 18th. The shares were purchased at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the purchase, the director directly owned 66,843 shares in the company, valued at $959,197.05. This represents a 17.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. lifted its stake in Surgery Partners by 239.6% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after purchasing an additional 2,051 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in Surgery Partners in the 2nd quarter worth $38,000. Fifth Third Bancorp boosted its position in Surgery Partners by 5,324.0% during the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after buying an additional 3,993 shares during the period. Vise Technologies Inc. bought a new position in Surgery Partners during the 3rd quarter worth approximately $191,000. Finally, Empowered Funds LLC bought a new stake in shares of Surgery Partners in the second quarter worth about $216,000.
More Surgery Partners News
Here are the key news stories impacting Surgery Partners this week:
- Positive Sentiment: Higher merger price is the main catalyst. The amended agreement reportedly increases the per-share consideration to $25 from $23.50 after a competing bid, with the Bon Secours affiliate’s transaction valued at up to $6 billion. A higher offer supports the deal’s value for shareholders, though completion remains a risk. Article: Surgery Partners Secures Improved Merger Terms
- Positive Sentiment: Adjusted Q3 earnings topped estimates. Surgery Partners reported adjusted EPS of $0.16, above the cited FactSet estimate of $0.11, providing some earnings support. Article: Q3 Adjusted EPS Earnings Flash
- Neutral Sentiment: Cash generation improved, despite weaker operating results. Operating cash flow was reported at $103.5 million and cash balances rose to $354.5 million, while revenue was $815.3 million—below estimates and slightly down year over year. Article: Q3 2026 Earnings Results
- Negative Sentiment: Profitability remains a concern, and a cash-flow valuation flags downside. The company reported a $21.1 million net loss attributable to common shareholders, with higher costs and lower operating profit. A separate analysis estimates SGRY may be 13% overvalued based on cash flow, which could limit further gains. Article: Surgery Partners Stock Could Be 13% Overvalued on Cash Flow
About Surgery Partners
Surgery Partners, Inc is a U.S. healthcare services company that owns and operates ambulatory surgery centers and surgical hospitals. Its facilities provide outpatient and inpatient surgical care across a range of specialties.
The company’s services include surgical procedures and related care delivered in partnership with physicians and healthcare professionals. Its network serves patients in multiple states across the United States.
Founded in 2004, Surgery Partners has expanded its network through acquisitions and partnerships with physicians and health systems.
Featured Stories
- Five stocks we like better than Surgery Partners
- DraftKings Just Lost 20%—And Its Biggest Gamble Is Still Ahead
- Barrick’s Earnings Beat Could Be Overshadowed by an Even Bigger Opportunity
- Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Wall Street May Be Making a Big Mistake With monday.com Stock
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.
